Task: Answer the multiple-choice question.
Question: Which compound exhibits a 4.603% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) O=C1CCC(C(=O)Nc2ccccc2N2CCOCC2)=NN1
(b) COCCCNC(=S)NCCCNc1nc2cc3c(cc2cc1C#N)OCO3
(c) COC(=O)C1=C(c2ccc(S(C)(=O)=O)cc2)C[C@@H]2CC[C@H]1N2C
Answer: a. O=C1CCC(C(=O)Nc2ccccc2N2CCOCC2)=NN1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1CCC(C(=O)Nc2ccccc2N2CCOCC2)=NN1
O=C1CCC(C(=O)Nc2ccccc2N2CCOCC2)=NN1
N-(2-morpholin-4-ylphenyl)-6-oxo-4,5-dihydro-1H-pyridazine-3-carboxamide